CELF1 Mediates Connexin 43 mRNA Degradation in Dilated Cardiomyopathy

Kuei-Ting Chang1, Ching-Feng Cheng1, Pei-Chih King1

  • 1From the Program in Molecular Medicine, National Yang-Ming University and Academia Sinica, Taipei, Taiwan (K.-T.C., G.-S.W.); Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan (K.-T.C., C.-F.C., P.-C.K., S.-Y.L., G.-S.W.); Department of Medical Research, Buddhist Tzu Chi General Hospital, Hualien, Taiwan (C.-F.C.); and Department of Pediatrics, Tzu Chi University, Hualien, Taiwan (C.-F.C.).

Circulation Research
|September 7, 2017
PubMed

Insights

Elevated CELF1 (CUGBP Elav-like family member 1) protein degrades Cx43 (connexin 43) mRNA, contributing to dilated cardiomyopathy (DCM). Reducing CELF1 in heart failure models improved cardiac function.

Area of Science:

  • Cardiovascular Biology
  • Molecular Mechanisms of Disease
  • RNA Biology

Background:

  • Downregulation of cardiac connexin 43 (Cx43) is linked to arrhythmia, dilated cardiomyopathy (DCM), and heart failure.
  • Elevated levels of the RNA-binding protein CELF1 (CUGBP Elav-like family member 1) are implicated in cardiac pathogenesis but the mechanism is unclear.

Purpose of the Study:

  • Investigate how CELF1 causes Cx43 mRNA degradation.
  • Determine if elevated CELF1 is a common feature in DCM hearts.

Main Methods:

  • RNA immunoprecipitation to identify CELF1 targets.
  • Assessed CELF1-RRP6 interaction and its role in Cx43 mRNA degradation.
  • Analyzed CELF1, RRP6, and Cx43 levels in DCM mouse models.

Main Results:

  • CELF1 directly mediates Cx43 mRNA degradation by binding its 3' UTR, requiring nuclear localization.
  • The exoribonuclease RRP6 is essential for CELF1-mediated Cx43 mRNA decay.
  • Increased CELF1 and RRP6, with decreased Cx43, were observed in various DCM models.
  • CELF1 depletion in infarcted hearts preserved Cx43 mRNA and ameliorated cardiac dysfunction.

Conclusions:

  • A mechanism is proposed where increased CELF1 downregulates Cx43 mRNA.
  • Elevated CELF1 plays a pathogenic role in dilated cardiomyopathy.
Abstract

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
648
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
553
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
632